Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Short Interest Down 65.3% in November

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) was the target of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 95,200 shares, a decrease of 65.3% from the November 15th total of 274,500 shares. Based on an average daily volume of 3,230,000 shares, the days-to-cover ratio is currently 0.0 days.

Quoin Pharmaceuticals Stock Up 5.3 %

Shares of NASDAQ:QNRX traded up $0.04 during midday trading on Wednesday, reaching $0.77. The company had a trading volume of 334,949 shares, compared to its average volume of 1,080,843. The stock has a market cap of $3.89 million, a PE ratio of -0.20 and a beta of 1.79. Quoin Pharmaceuticals has a 1-year low of $0.48 and a 1-year high of $6.18. The business’s 50 day moving average price is $0.67 and its 200 day moving average price is $0.64.

About Quoin Pharmaceuticals

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.